Abstract
Stem cell gene therapy strategies for AIDS require that differentiation-inducing stromal elements of HIV-infected individuals remain functionally intact to support the maturation of exogenous progenitor cells into mature CD4+ cells. To investigate the feasibility of stem cell reconstitution strategies in AIDS, we used the SCID-hu mouse to examine the ability of HIV-infected CD4+ cell-depleted human thymic implants to support renewed thymopoiesis. Here we report that following treatment of these implants with antiretroviral drugs, new thymopoiesis is initiated. This suggests that antiviral therapies might allow de novo production of T lymphocytes and provides support for the concept of therapeutic strategies aimed at reconstitution of the peripheral CD4+ T-cell compartment.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ho, D.D. et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123–126 (1995).
Wei, X. et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117–122 (1995).
Papiernik, M. et al. Thymic abnormalities in fetuses aborted from human immunodeficiency virus type 1 seropositive women. Pediatrics 89, 297–301 (1992).
Schuurman, H.J. et al. The thymus in acquired immunodeficiency syndrome: Comparison with other types of immunodeficiency diseases and presence of components in human immunodeficiency virus type 1. Am. J. Pathol. 134, 1329–1338 (1989).
Grody, W., Fligiel, S. & Naeim, F. Thymus involution in the acquired immunodeficiency syndrome. Am. J. Clin. Pathol. 84, 85–95 (1985).
Joshi, V.V. et al. Thymus biopsy in children with acquired immunodeficiency syndrome. Arch. Pathol. Lab. Med. 110: 837–842 (1986).
Rosenzweig, M., Clark, D.P. & Gaulton, G.N. Selective thymocyte depletion in neonatal HIV-1 thymic infection. AIDS 7, 1601–1605 (1993).
McCune, J.M. et al. The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science 241, 1632–1639 (1988).
Namikawa, R., Weilbaecher, K.N., Kaneshima, H., Yee, E.J. & McCune, J.M. Long-term human hematopoiesis in the SCID-hu mouse. J. Exp. Med. 172, 1055–1063 (1990).
Aldrovandi, G.M. et al. HIV-1 infection of the SCID-hu mouse: An animal model for virus pathogenesis. Nature 363, 732–736 (1993).
Bonyhadi, M.L. et al. HIV induces thymus depletion in vivo. Nature 363, 728–736 (1993).
Stanley, S.K. et al. Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J. Exp. Med. 178, 1151–1163 (1993).
Kollmann, T.R. et al. Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID-hu mice after peripheral inoculation with HIV-1. J. Exp. Med. 179, 513–522 (1994).
Akkina, R.K., Rosenblatt, J.D., Campbell, A.G., Chen, I.S.Y. & Zack, J.A. Modeling human stem Cell gene therapy in the SCID-hu mouse. Blood 84, 1393–1398 (1994).
An, D.S. et al. High-efficiency gene transduction of human T-Cell progenitors. J. Virol. 71, 1397–1404 (1997).
Jamieson, B.D. et al. Requirement of HIV-1 nef for in vivo replication and pathogenesis. J. Virol. 68, 3478–3485 (1994).
Jamieson, B.D., Pang, S., Aldrovandi, G.M., Zha, J. & Zack, J.A. In vivo pathogenic properties of two clonal human immunodeficiency virus type 1 isolates. J. Virol. 69, 6259–6264 (1995).
Aldrovandi, G.M. & Zack, J.A. Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice. J. Virol. 70, 1505–1511 (1996).
Jamieson, B.D., Uittenbogaart, C.H., Schmid, I. & Zack, J.A. High viral burden and rapid CD4+ Cell depletion in HIV-1-infected SCID-hu mice suggest direct viral killing of thymocytes in vivo. J. Virol. (in the press).
Kaneshima, H. et al. Human immunodeficiency virus infection of human lymph nodes in the SCID-hu mouse. Proc. Natl. Acad. Sci. USA 88, 4523–4527 (1991).
McCune, J.M., Namikawa, R., Shih, C.-C., Rabin, L. & Kaneshima, H. Suppression of HIV infection in AZT-treated SCID-hu mice. Science 247, 564–566 (1990).
Zack, J.A. et al. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure. Cell 61, 213–222 (1990).
Kaplan, A.H. et al. Partial inhibition of human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles. J. Virol. 67, 4050–4055 (1993).
Jaskolski, M. et al. Structure at 2.5-Å resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor. Biochemistry 30, 1600–1609 (1991).
Lech, W.J. et al. In vivo sequence diversity of the protease of the human immunodeficiency virus type 1: Presence of protease inhibitor resistant variants in untreated subjects. J. Virol. 70, 2038–2045 (1996).
Kaplan, A.H. et al. Selection of multiple HIV-1 variants with decreased sensitivity to an inhibitor of the viral protease. Proc. Natl. Acad. Sci. USA 91, 5597–5601 (1994).
Ho, D.D. et al. Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitor. J. Virol. 68, 2016–2020 (1994).
Autran, B. et al. Positive effects of combined antiretroviral therapy on CD4+ T-Cell homeostasis and function in advanced HIV disease. Science 27, 112–116 (1997).
Sato, A. et al. A simple and rapid method for preliminary evaluation of in vivo efficacy of anti-HIV compounds in mice. Antiviral Res. 27, 151–163 (1995).
Vacca, J.P. et al. L-735,524: An orally bioavailable human immunodeficiency virus type 1 protease inhibitor. Proc. Natl. Acad. Sci. USA 91, 4096–4100 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Withers-Ward, E., Amado, R., Koka, P. et al. Transient renewal of thymopoiesis in HIV-infected human thymic implants following antiviral therapy. Nat Med 3, 1102–1109 (1997). https://doi.org/10.1038/nm1097-1102
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm1097-1102